Targeting gut microbiota: a potential therapeutic approach for tumor microenvironment in glioma

Area of Science:

• Neuro-oncology
• Microbiome research
• Immunology

Background:

• Glioma is a highly lethal brain tumor with complex pathogenesis and limited treatment options.
• The tumor microenvironment (TME) is crucial for glioma development, recurrence, and progression.
• The gut microbiota's role in modulating the TME and influencing glioma is increasingly recognized.

Purpose of the Study:

• To elucidate the intricate role of gut microbiota in the glioma tumor microenvironment (TME).
• To explore the association between gut microbiota composition and glioma progression.
• To identify potential therapeutic strategies targeting the gut microbiota for glioma intervention.

Main Methods:

• Literature review and synthesis of current research on gut microbiota, TME, and glioma.
• Analysis of the brain-gut axis communication pathways.
• Investigation of the impact of gut microbiota on the tumor immune microenvironment (TIME) and inflammation.

Main Results:

• Gut microbiota significantly influences glioma through the brain-gut axis.
• Modulation of the TME and TIME by gut bacteria affects glioma development and progression.
• Gut microbiota alterations are linked to glioma pathogenesis and therapeutic response.

Conclusions:

• Gut microbiota represents a promising therapeutic target for glioma management.
• Interventions modulating gut microbiota could enhance glioma treatment efficacy.
• Further research into the gut microbiota-glioma axis may unlock novel treatment avenues.